Drug · DIN 02350211
RANITIDINE TABLETS
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 10, 2025.
- Drug Identification Number (DIN)
- 02350211
- Company (DIN owner)
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ranitidine A02BA02
- Class
- Human
- Record last updated
- July 11, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANITIDINE (RANITIDINE HYDROCHLORIDE) | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 28, 2010: NOC 11317Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named RANITIDINE TABLETS
- DIN 02350203 · Cancelled Pre Market